Skip to main content
. Author manuscript; available in PMC: 2015 Nov 27.
Published in final edited form as: Blood Cells Mol Dis. 2010 Nov 10;46(1):95–102. doi: 10.1016/j.bcmd.2010.10.006

Table 3.

Frequency of genotypes for GD1 patients with and without Parkinsonism, after matching.

Patients without
Parkinsonism
reported
Patients with
Parkinsonism
reported
p-value
Patients enrolled 649 68
Patients reporting genotype, n (%) n = 438 (67.5) n = 59 (86.8) 0.4149
Genotypec, n(%)
  N370S/N370S 172 (39.2) 27 (45.8)
  N370S/L444P 71 (16.2) 9 (15.3)
  N370S/84GG 58 (13.2) 4 (6.8)
  N370S/?a 58 (13.2) 8 (13.6)
  N370S/rare alleleb 40 (9.1) 5 (8.5)
  N370S/IVS2+1 13 (3.0) 2 (3.4)
  L444P/rare alleleb 5 (1.1) 2 (3.4)
  Rare alleleb/rare alleleb 5 (1.1)
  L444P/?a 4 (0.9)
  84GG/rare alleleb 3 (0.7)
  Rare alleleb/?a 3 (0.7)
  N370S/D409H 2 (0.5)
  84GG/?a 1 (0.2)
  IVS2+1/rare alleleb 1 (0.2)
  IVS2+1/?a 1 (0.2)
  ?a/?a 1 (0.2) 2 (3.4)
a

Results of genotype test did not match any tested mutations.

b

Rare allele is defined as known allele which is not N370S, L444P, IVS2+1, D409H or 84GG.

c

Calculations based on the number of patients reporting genotype.